about
Serum fatty acid profile in psoriasis and its comorbidity.Effect of psoriasis activity on serum adiponectin and leptin levels.Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis.Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients.Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK).Serum YKL-40 as a potential biomarker of inflammation in psoriasis.Serum irisin levels in patients with psoriasis.Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels.The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels.Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.Upregulation of the sFas/sFasL system in psoriatic patients.Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.Influence of narrowband ultraviolet B phototherapy on serum tumour necrosis factor-like weak inducer of apoptosis (TWEAK) in patients with psoriasis.Serum adiponectin and leptin levels in psoriatic patients according to topical treatment.Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR).Plasma TGF-beta1, TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activityEffect of psoriasis activity on metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in plasma and lesional scalesEffect of psoriasis therapy on VEGF and its soluble receptors serum concentrationsPlasma and scales levels of interleukin 18 in comparison with other possible clinical and laboratory biomarkers of psoriasis activityIncidence of pemphigus vulgaris and pemphigus foliaceus in North-East Poland (Podlaskie Province) - a 15-year (2001-2015) bicentric retrospective study
P50
Q33840850-7F21535F-20D5-4E90-B3A4-48231E1D01C2Q35620533-A1B6944C-27CA-4ABD-90F6-7B3338D8A940Q37575141-6A01C915-F379-416D-8D98-3D294BBDB20CQ37642111-6A2F4D0F-E8EF-495B-96FE-0551E87A6221Q39983757-55C5C5FC-2067-4302-92DB-E91528A628E2Q40215575-7DF26F77-6EC3-4839-8DDA-0B305A48F45FQ40482297-257BAEBC-DC1D-49E2-B9A6-415398E5BD3EQ40680047-6171241F-2997-437D-B1D4-92CF171A2DCCQ41041187-00D77FFA-3C26-48A1-B64B-E97E26C69256Q44642331-ED4EE91A-30D2-4DE0-A73C-1114958C8DEEQ46136294-23C755BE-42C0-451D-AF8B-1CF598824BBAQ46574517-FB965F75-45E9-41B8-B74E-CAF1C400E901Q51835509-0B9F493B-ECE2-451F-936C-B16BF7733517Q54273992-1D56C46C-05D0-435E-93E9-91E1EC43BCFAQ54352930-9AFAB130-CFF6-43A0-A623-BBE4CBB6B4C2Q54637916-8C2A38FD-220F-4CD9-9463-7936EC74C058Q54999009-07CE2983-B991-4E8C-8BDC-79CE740D676EQ79775795-9AAB2DBD-D196-4D94-85B8-90E83FF46360Q83061344-7205B492-4BED-4874-AF56-4A98CECFA340Q83647539-B363F1AE-7FE1-4A96-B624-8381E3610202Q83966456-FD96F152-3613-4293-BD1F-B1EDC7F62AA3Q89004942-71692BB8-557B-4FB3-9876-91582CE6D137
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-5923-910X
@en
name
Iwona Flisiak
@ast
Iwona Flisiak
@ca
Iwona Flisiak
@cs
Iwona Flisiak
@en
Iwona Flisiak
@es
Iwona Flisiak
@gl
Iwona Flisiak
@hr
Iwona Flisiak
@hsb
Iwona Flisiak
@it
Iwona Flisiak
@nl
type
label
Iwona Flisiak
@ast
Iwona Flisiak
@ca
Iwona Flisiak
@cs
Iwona Flisiak
@en
Iwona Flisiak
@es
Iwona Flisiak
@gl
Iwona Flisiak
@hr
Iwona Flisiak
@hsb
Iwona Flisiak
@it
Iwona Flisiak
@nl
prefLabel
Iwona Flisiak
@ast
Iwona Flisiak
@ca
Iwona Flisiak
@cs
Iwona Flisiak
@en
Iwona Flisiak
@es
Iwona Flisiak
@gl
Iwona Flisiak
@hr
Iwona Flisiak
@hsb
Iwona Flisiak
@it
Iwona Flisiak
@nl
P214
P106
P1153
55992651400
P1412
P1559
Iwona Flisiak
@pl
P21
P214
P27
P31
P3124
P496
0000-0002-5923-910X
P735
P7859
viaf-315213330